Medical device certification relies on a higher level of documentation than … [Read More...] about Complimentary whitepaper: “5 Essential Steps for Medical Device Certification”
Main Content
White Papers
See why the Q-Sub Program is key to regulatory strategy
The Q-Sub Program gives you pre-submission feedback straight from the FDA. … [Read More...] about See why the Q-Sub Program is key to regulatory strategy
Sponsored Content
Hobson & Motzer: Investing in the Future
An Early Adopter Innovation is in Connecticut-based Hobson & Motzer’s DNA. Throughout the precision metal manufacturer’s 110-year history, the ability to respond to changing demands and market conditions, and to leverage evolving technologies has set it apart in the manufacturing world. “We were early adopters of jig boring, visual grinding, EDM, and wire” says company […]
You’ve Got Data. Is It Helping or Hurting?
By Bob Steller, Industry Principal – Life Sciences Opportunity could be staring you in the face, but you might not recognize it. As a Life Sciences company, you have so much data. Are you making the best use of it? I was recently talking to a customer who has 90 reports, but most of the information […]
Cordis high resolution electronic proportional pressure controls
Precise, linear pressure control within a closed-loop system with ultra-high resolution and repeatability The Clippard Cordis is a revolutionary microcontroller primed for escape velocity from a proportional control market that has grown stagnant. Built with the highest quality Clippard proportional valves at its heart, the Cordis is designed to outperform the competition in every way. With […]
Additive Manufacturing Makes Complex, First-in-Industry Medical Devices Possible
Many innovative, next-generation medical devices and components can only be made with additive manufacturing By Tyler Stark, Senior Director of Additive Manufacturing and Innovation, Spectrum Plastics Group Additive manufacturing (AM), also known as 3D printing, comprises an innovative suite of advanced technologies that enable the fabrication of a variety of components and products, with remarkably […]
Mergers & Acquisitions.
Device developer SeaStar Medical hires chief medical officer
SeaStar Medical has hired Dr. Kevin Chung as chief medical officer of the medtech developer starting July 1. Denver-based SeaStar is developing a platform therapy focused on hyperinflammation of vital organs. The company’s Selective Cytopheretic Device was designated as a breakthrough device by the FDA earlier this year. SeaStar is set to go public in the […]
Report: Dexcom in talks to acquire Insulet
Major players in the diabetes space could join forces as Dexcom (Nasdaq:DXCM) is reportedly in discussions to acquire Insulet (Nasdaq:PODD). Bloomberg reported today that people “with knowledge of the matter” have said talks are ongoing over a potential acquisition and even said an agreement could be reached “in the coming weeks.” Bloomberg’s sources preferred to remain anonymous […]
Alcon to pay $60M to acquire Kala Pharmaceuticals’ dry eye treatment
Alcon (NYSE:ACL) announced today that it agreed to acquire Eysuvis pharmaceutical eye drops from Kala Pharmaceuticals. Geneva, Switzerland-based Alcon will pay $60 million upfront to Kala for the dry eye treatment. As part of the agreement, the company will also acquire Kala’s Inveltys corticosteroid for twice-per-day treatment of post-operative inflammation and pain following ocular surgery. Get the […]
Medtronic completes Intersect ENT acquisition
Medtronic (NYSE:MDT) announced that it completed its previously announced $1.1 billion acquisition of Intersect ENT (Nasdaq:XENT). Fridley, Minnesota-based Medtronic announced in August 2021 that it would acquire all outstanding shares of the Menlo Park, California-based sinus implant maker for $28.25 per share in an all-cash transaction. As a result of the transaction, Medtronic acquires Intersect […]
Medtronic must sell Intersect ENT subsidiary to satisfy FTC concerns
The Federal Trade Commission has issued a proposed order to require Medtronic (NYSE:MDT) to sell a subsidiary of Intersect ENT within 10 days of completing its $1.1 billion acquisition of Intersect ENT. The commission announced May 10 that it voted 4-0 to issue its complaint and accept the proposed consent order for public comment. Under […]
Pfizer to shell out $11.6B for migraine drugmaker Biohaven
Pfizer (NYSE:PFE) today announced that it has entered into an agreement to acquire Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN), which is best known for Nurtec ODT (rimegepant), a dual-acting migraine therapy. Pfizer will pay $148.50 per share in cash to acquire Biohaven, totaling approximately $11.6 billion. Get the full story from our sister site, Pharmaceutical […]
Conmed beats The Street in Q1, announces $145M deal to acquire In2Bones
Conmed (NSDQ:CNMD) announced that it will acquire In2Bones Global for more than $145 million after it posted first-quarter results that beat the overall consensus on Wall Street. The Largo, Florida–based minimally invasive medical device company on yesterday evening reported profits of $14.96 million, or 47¢ per share, on sales of $242.3 million for the three […]
